diff --git a/examples/PXD042173/PXD042173.sdrf.tsv b/examples/PXD042173/PXD042173.sdrf.tsv
new file mode 100644
index 00000000..c3d229eb
--- /dev/null
+++ b/examples/PXD042173/PXD042173.sdrf.tsv
@@ -0,0 +1,178 @@
+source name	characteristics[organism]	characteristics[organism part]	characteristics[cell type]	characteristics[disease]	characteristics[age]	characteristics[sex]	characteristics[biological replicate]	characteristics[material type]	characteristics[sample type]	characteristics[enrichment process]	characteristics[crosslink distance]	characteristics[crosslinking reaction time]	characteristics[crosslinking temperature]	assay name	technology type	comment[data file]	comment[technical replicate]	comment[fraction identifier]	comment[label]	comment[instrument]	comment[proteomics data acquisition method]	comment[cleavage agent details]	comment[cleavage agent details]	comment[modification parameters]	comment[modification parameters]	comment[dissociation method]	comment[collision energy]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	comment[fractionation method]	comment[chemical cross-linking coupled with ms]	comment[cross-linker]	comment[crosslink enrichment method]	comment[crosslinker concentration]	comment[quenching reagent]	comment[reduction reagent]	comment[alkylation reagent]	comment[sdrf version]	comment[sdrf template]	comment[sdrf template]	comment[sdrf template]
+PXD042173-batch1	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	1	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20210727_MxR_FDR_firstbatch_DSSOplate2_B12	proteomic profiling by mass spectrometry	L1_20210727_MxR_FDR_firstbatch_DSSOplate2_B12.raw	1	1	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch1	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	1	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20210727_MxR_FDR_firstbatch_DSSOplate2_E12	proteomic profiling by mass spectrometry	L1_20210727_MxR_FDR_firstbatch_DSSOplate2_E12.raw	1	2	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch1	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	1	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20210727_MxR_FDR_firstbatch_DSSOplate2_H12	proteomic profiling by mass spectrometry	L1_20210727_MxR_FDR_firstbatch_DSSOplate2_H12.raw	1	3	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch1	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	1	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20210806_MxR_FDR_firstbatch_DSSOplate_C10	proteomic profiling by mass spectrometry	L1_20210806_MxR_FDR_firstbatch_DSSOplate_C10.raw	1	4	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch1	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	1	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20210806_MxR_FDR_firstbatch_DSSOplate_C11	proteomic profiling by mass spectrometry	L1_20210806_MxR_FDR_firstbatch_DSSOplate_C11.raw	1	5	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch1	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	1	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20210806_MxR_FDR_firstbatch_DSSOplate_C12	proteomic profiling by mass spectrometry	L1_20210806_MxR_FDR_firstbatch_DSSOplate_C12.raw	1	6	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch1	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	1	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20210806_MxR_FDR_firstbatch_DSSOplate_C6	proteomic profiling by mass spectrometry	L1_20210806_MxR_FDR_firstbatch_DSSOplate_C6.raw	1	7	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch1	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	1	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20210806_MxR_FDR_firstbatch_DSSOplate_C7	proteomic profiling by mass spectrometry	L1_20210806_MxR_FDR_firstbatch_DSSOplate_C7.raw	1	8	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch1	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	1	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20210806_MxR_FDR_firstbatch_DSSOplate_C8	proteomic profiling by mass spectrometry	L1_20210806_MxR_FDR_firstbatch_DSSOplate_C8.raw	1	9	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch1	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	1	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20210806_MxR_FDR_firstbatch_DSSOplate_C9	proteomic profiling by mass spectrometry	L1_20210806_MxR_FDR_firstbatch_DSSOplate_C9.raw	1	10	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch1	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	1	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20210806_MxR_FDR_firstbatch_DSSOplate_D1	proteomic profiling by mass spectrometry	L1_20210806_MxR_FDR_firstbatch_DSSOplate_D1.raw	1	11	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch1	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	1	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20210806_MxR_FDR_firstbatch_DSSOplate_D2	proteomic profiling by mass spectrometry	L1_20210806_MxR_FDR_firstbatch_DSSOplate_D2.raw	1	12	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch1	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	1	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20210806_MxR_FDR_firstbatch_DSSOplate_D3	proteomic profiling by mass spectrometry	L1_20210806_MxR_FDR_firstbatch_DSSOplate_D3.raw	1	13	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch1	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	1	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20210806_MxR_FDR_firstbatch_DSSOplate_D4	proteomic profiling by mass spectrometry	L1_20210806_MxR_FDR_firstbatch_DSSOplate_D4.raw	1	14	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch1	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	1	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20210806_MxR_FDR_firstbatch_DSSOplate_D5	proteomic profiling by mass spectrometry	L1_20210806_MxR_FDR_firstbatch_DSSOplate_D5.raw	1	15	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch1	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	1	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20210806_MxR_FDR_firstbatch_DSSOplate_D6	proteomic profiling by mass spectrometry	L1_20210806_MxR_FDR_firstbatch_DSSOplate_D6.raw	1	16	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch1	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	1	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20210806_MxR_FDR_firstbatch_DSSOplate_D7	proteomic profiling by mass spectrometry	L1_20210806_MxR_FDR_firstbatch_DSSOplate_D7.raw	1	17	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch1	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	1	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20210806_MxR_FDR_firstbatch_DSSOplate_D8	proteomic profiling by mass spectrometry	L1_20210806_MxR_FDR_firstbatch_DSSOplate_D8.raw	1	18	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch1	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	1	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20210811_MxR_FDR_firstbatch_DSSOplate_D10_remeasure	proteomic profiling by mass spectrometry	L1_20210811_MxR_FDR_firstbatch_DSSOplate_D10_remeasure.raw	1	19	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch1	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	1	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20210811_MxR_FDR_firstbatch_DSSOplate_D11	proteomic profiling by mass spectrometry	L1_20210811_MxR_FDR_firstbatch_DSSOplate_D11.raw	1	20	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch1	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	1	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20210811_MxR_FDR_firstbatch_DSSOplate_D12	proteomic profiling by mass spectrometry	L1_20210811_MxR_FDR_firstbatch_DSSOplate_D12.raw	1	21	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch1	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	1	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20210811_MxR_FDR_firstbatch_DSSOplate_D9_remeasure	proteomic profiling by mass spectrometry	L1_20210811_MxR_FDR_firstbatch_DSSOplate_D9_remeasure.raw	1	22	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch1	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	1	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20210811_MxR_FDR_firstbatch_DSSOplate_E10	proteomic profiling by mass spectrometry	L1_20210811_MxR_FDR_firstbatch_DSSOplate_E10.raw	1	23	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch1	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	1	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20210811_MxR_FDR_firstbatch_DSSOplate_E11	proteomic profiling by mass spectrometry	L1_20210811_MxR_FDR_firstbatch_DSSOplate_E11.raw	1	24	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch1	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	1	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20210811_MxR_FDR_firstbatch_DSSOplate_E12	proteomic profiling by mass spectrometry	L1_20210811_MxR_FDR_firstbatch_DSSOplate_E12.raw	1	25	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch1	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	1	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20210811_MxR_FDR_firstbatch_DSSOplate_E1_remeasure	proteomic profiling by mass spectrometry	L1_20210811_MxR_FDR_firstbatch_DSSOplate_E1_remeasure.raw	1	26	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch1	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	1	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20210811_MxR_FDR_firstbatch_DSSOplate_E2	proteomic profiling by mass spectrometry	L1_20210811_MxR_FDR_firstbatch_DSSOplate_E2.raw	1	27	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch1	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	1	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20210811_MxR_FDR_firstbatch_DSSOplate_E3	proteomic profiling by mass spectrometry	L1_20210811_MxR_FDR_firstbatch_DSSOplate_E3.raw	1	28	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch1	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	1	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20210811_MxR_FDR_firstbatch_DSSOplate_E4	proteomic profiling by mass spectrometry	L1_20210811_MxR_FDR_firstbatch_DSSOplate_E4.raw	1	29	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch1	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	1	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20210811_MxR_FDR_firstbatch_DSSOplate_E5	proteomic profiling by mass spectrometry	L1_20210811_MxR_FDR_firstbatch_DSSOplate_E5.raw	1	30	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch1	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	1	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20210811_MxR_FDR_firstbatch_DSSOplate_E6	proteomic profiling by mass spectrometry	L1_20210811_MxR_FDR_firstbatch_DSSOplate_E6.raw	1	31	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch1	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	1	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20210811_MxR_FDR_firstbatch_DSSOplate_E7	proteomic profiling by mass spectrometry	L1_20210811_MxR_FDR_firstbatch_DSSOplate_E7.raw	1	32	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch1	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	1	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20210811_MxR_FDR_firstbatch_DSSOplate_E8	proteomic profiling by mass spectrometry	L1_20210811_MxR_FDR_firstbatch_DSSOplate_E8.raw	1	33	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch1	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	1	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20210811_MxR_FDR_firstbatch_DSSOplate_E9	proteomic profiling by mass spectrometry	L1_20210811_MxR_FDR_firstbatch_DSSOplate_E9.raw	1	34	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch1	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	1	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20210811_MxR_FDR_firstbatch_DSSOplate_F1	proteomic profiling by mass spectrometry	L1_20210811_MxR_FDR_firstbatch_DSSOplate_F1.raw	1	35	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch1	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	1	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20210811_MxR_FDR_firstbatch_DSSOplate_F2	proteomic profiling by mass spectrometry	L1_20210811_MxR_FDR_firstbatch_DSSOplate_F2.raw	1	36	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch1	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	1	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20210811_MxR_FDR_firstbatch_DSSOplate_F3	proteomic profiling by mass spectrometry	L1_20210811_MxR_FDR_firstbatch_DSSOplate_F3.raw	1	37	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch2	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	2	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211004_MxR_secondbatch_DSSOplate_B10	proteomic profiling by mass spectrometry	L1_20211004_MxR_secondbatch_DSSOplate_B10.raw	1	1	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch2	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	2	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211004_MxR_secondbatch_DSSOplate_B11	proteomic profiling by mass spectrometry	L1_20211004_MxR_secondbatch_DSSOplate_B11.raw	1	2	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch2	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	2	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211004_MxR_secondbatch_DSSOplate_B12	proteomic profiling by mass spectrometry	L1_20211004_MxR_secondbatch_DSSOplate_B12.raw	1	3	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch2	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	2	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211004_MxR_secondbatch_DSSOplate_B1_B2	proteomic profiling by mass spectrometry	L1_20211004_MxR_secondbatch_DSSOplate_B1_B2.raw	1	4	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch2	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	2	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211004_MxR_secondbatch_DSSOplate_B3_B4	proteomic profiling by mass spectrometry	L1_20211004_MxR_secondbatch_DSSOplate_B3_B4.raw	1	5	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch2	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	2	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211004_MxR_secondbatch_DSSOplate_B5_B6	proteomic profiling by mass spectrometry	L1_20211004_MxR_secondbatch_DSSOplate_B5_B6.raw	1	6	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch2	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	2	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211004_MxR_secondbatch_DSSOplate_B7_B8	proteomic profiling by mass spectrometry	L1_20211004_MxR_secondbatch_DSSOplate_B7_B8.raw	1	7	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch2	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	2	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211004_MxR_secondbatch_DSSOplate_B9	proteomic profiling by mass spectrometry	L1_20211004_MxR_secondbatch_DSSOplate_B9.raw	1	8	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch2	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	2	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211004_MxR_secondbatch_DSSOplate_C1	proteomic profiling by mass spectrometry	L1_20211004_MxR_secondbatch_DSSOplate_C1.raw	1	9	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch2	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	2	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211004_MxR_secondbatch_DSSOplate_C2	proteomic profiling by mass spectrometry	L1_20211004_MxR_secondbatch_DSSOplate_C2.raw	1	10	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch2	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	2	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211004_MxR_secondbatch_DSSOplate_C3	proteomic profiling by mass spectrometry	L1_20211004_MxR_secondbatch_DSSOplate_C3.raw	1	11	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch2	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	2	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211004_MxR_secondbatch_DSSOplate_C4_152127	proteomic profiling by mass spectrometry	L1_20211004_MxR_secondbatch_DSSOplate_C4_152127.raw	1	12	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch2	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	2	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211004_MxR_secondbatch_DSSOplate_C4_212733	proteomic profiling by mass spectrometry	L1_20211004_MxR_secondbatch_DSSOplate_C4_212733.raw	1	13	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch2	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	2	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211004_MxR_secondbatch_DSSOplate_C5_152127	proteomic profiling by mass spectrometry	L1_20211004_MxR_secondbatch_DSSOplate_C5_152127.raw	1	14	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch2	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	2	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211004_MxR_secondbatch_DSSOplate_C5_212733	proteomic profiling by mass spectrometry	L1_20211004_MxR_secondbatch_DSSOplate_C5_212733.raw	1	15	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch2	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	2	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211004_MxR_secondbatch_DSSOplate_C6	proteomic profiling by mass spectrometry	L1_20211004_MxR_secondbatch_DSSOplate_C6.raw	1	16	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch2	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	2	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211004_MxR_secondbatch_DSSOplate_C7	proteomic profiling by mass spectrometry	L1_20211004_MxR_secondbatch_DSSOplate_C7.raw	1	17	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch2	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	2	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211004_MxR_secondbatch_DSSOplate_C8	proteomic profiling by mass spectrometry	L1_20211004_MxR_secondbatch_DSSOplate_C8.raw	1	18	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch2	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	2	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211004_MxR_secondbatch_DSSOplate_C9_C10	proteomic profiling by mass spectrometry	L1_20211004_MxR_secondbatch_DSSOplate_C9_C10.raw	1	19	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch2	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	2	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211004_MxR_secondbatch_DSSOplate_D11_D12	proteomic profiling by mass spectrometry	L1_20211004_MxR_secondbatch_DSSOplate_D11_D12.raw	1	20	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch2	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	2	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211004_MxR_secondbatch_DSSOplate_D1_D2	proteomic profiling by mass spectrometry	L1_20211004_MxR_secondbatch_DSSOplate_D1_D2.raw	1	21	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch2	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	2	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211004_MxR_secondbatch_DSSOplate_D3_D4	proteomic profiling by mass spectrometry	L1_20211004_MxR_secondbatch_DSSOplate_D3_D4.raw	1	22	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch2	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	2	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211004_MxR_secondbatch_DSSOplate_D5_D6	proteomic profiling by mass spectrometry	L1_20211004_MxR_secondbatch_DSSOplate_D5_D6.raw	1	23	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch2	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	2	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211004_MxR_secondbatch_DSSOplate_D7_D8	proteomic profiling by mass spectrometry	L1_20211004_MxR_secondbatch_DSSOplate_D7_D8.raw	1	24	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch2	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	2	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211004_MxR_secondbatch_DSSOplate_D9_D10	proteomic profiling by mass spectrometry	L1_20211004_MxR_secondbatch_DSSOplate_D9_D10.raw	1	25	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch2	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	2	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211004_MxR_secondbatch_DSSOplate_E11_E12	proteomic profiling by mass spectrometry	L1_20211004_MxR_secondbatch_DSSOplate_E11_E12.raw	1	26	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch2	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	2	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211004_MxR_secondbatch_DSSOplate_E1_E2	proteomic profiling by mass spectrometry	L1_20211004_MxR_secondbatch_DSSOplate_E1_E2.raw	1	27	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch2	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	2	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211004_MxR_secondbatch_DSSOplate_E3_E4	proteomic profiling by mass spectrometry	L1_20211004_MxR_secondbatch_DSSOplate_E3_E4.raw	1	28	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch2	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	2	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211004_MxR_secondbatch_DSSOplate_E5_E6	proteomic profiling by mass spectrometry	L1_20211004_MxR_secondbatch_DSSOplate_E5_E6.raw	1	29	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch2	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	2	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211004_MxR_secondbatch_DSSOplate_E7_E8	proteomic profiling by mass spectrometry	L1_20211004_MxR_secondbatch_DSSOplate_E7_E8.raw	1	30	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch2	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	2	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211004_MxR_secondbatch_DSSOplate_E9_E10	proteomic profiling by mass spectrometry	L1_20211004_MxR_secondbatch_DSSOplate_E9_E10.raw	1	31	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch2	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	2	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211004_MxR_secondbatch_DSSOplate_F11_F12	proteomic profiling by mass spectrometry	L1_20211004_MxR_secondbatch_DSSOplate_F11_F12.raw	1	32	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch2	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	2	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211004_MxR_secondbatch_DSSOplate_F1_F2	proteomic profiling by mass spectrometry	L1_20211004_MxR_secondbatch_DSSOplate_F1_F2.raw	1	33	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch2	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	2	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211004_MxR_secondbatch_DSSOplate_F3_F4	proteomic profiling by mass spectrometry	L1_20211004_MxR_secondbatch_DSSOplate_F3_F4.raw	1	34	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch2	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	2	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211004_MxR_secondbatch_DSSOplate_F5_F6	proteomic profiling by mass spectrometry	L1_20211004_MxR_secondbatch_DSSOplate_F5_F6.raw	1	35	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch2	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	2	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211004_MxR_secondbatch_DSSOplate_F7_F8	proteomic profiling by mass spectrometry	L1_20211004_MxR_secondbatch_DSSOplate_F7_F8.raw	1	36	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch2	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	2	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211004_MxR_secondbatch_DSSOplate_F9_F10	proteomic profiling by mass spectrometry	L1_20211004_MxR_secondbatch_DSSOplate_F9_F10.raw	1	37	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch3	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	3	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211118_MxR_thirdbatch_DSSOplate_B11_B12	proteomic profiling by mass spectrometry	L1_20211118_MxR_thirdbatch_DSSOplate_B11_B12.raw	1	1	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch3	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	3	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211118_MxR_thirdbatch_DSSOplate_B7_B8	proteomic profiling by mass spectrometry	L1_20211118_MxR_thirdbatch_DSSOplate_B7_B8.raw	1	2	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch3	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	3	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211118_MxR_thirdbatch_DSSOplate_B9_B10	proteomic profiling by mass spectrometry	L1_20211118_MxR_thirdbatch_DSSOplate_B9_B10.raw	1	3	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch3	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	3	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211118_MxR_thirdbatch_DSSOplate_C11_C12_212733	proteomic profiling by mass spectrometry	L1_20211118_MxR_thirdbatch_DSSOplate_C11_C12_212733.raw	1	4	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch3	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	3	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211118_MxR_thirdbatch_DSSOplate_C1_C2	proteomic profiling by mass spectrometry	L1_20211118_MxR_thirdbatch_DSSOplate_C1_C2.raw	1	5	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch3	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	3	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211118_MxR_thirdbatch_DSSOplate_C3_C4	proteomic profiling by mass spectrometry	L1_20211118_MxR_thirdbatch_DSSOplate_C3_C4.raw	1	6	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch3	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	3	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211118_MxR_thirdbatch_DSSOplate_C5_C6	proteomic profiling by mass spectrometry	L1_20211118_MxR_thirdbatch_DSSOplate_C5_C6.raw	1	7	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch3	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	3	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211118_MxR_thirdbatch_DSSOplate_C7_C8	proteomic profiling by mass spectrometry	L1_20211118_MxR_thirdbatch_DSSOplate_C7_C8.raw	1	8	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch3	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	3	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211118_MxR_thirdbatch_DSSOplate_C9_C10	proteomic profiling by mass spectrometry	L1_20211118_MxR_thirdbatch_DSSOplate_C9_C10.raw	1	9	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch3	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	3	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211118_MxR_thirdbatch_DSSOplate_D11_D12	proteomic profiling by mass spectrometry	L1_20211118_MxR_thirdbatch_DSSOplate_D11_D12.raw	1	10	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch3	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	3	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211118_MxR_thirdbatch_DSSOplate_D1_D2	proteomic profiling by mass spectrometry	L1_20211118_MxR_thirdbatch_DSSOplate_D1_D2.raw	1	11	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch3	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	3	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211118_MxR_thirdbatch_DSSOplate_D3_D4	proteomic profiling by mass spectrometry	L1_20211118_MxR_thirdbatch_DSSOplate_D3_D4.raw	1	12	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch3	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	3	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211118_MxR_thirdbatch_DSSOplate_D5_D6	proteomic profiling by mass spectrometry	L1_20211118_MxR_thirdbatch_DSSOplate_D5_D6.raw	1	13	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch3	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	3	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211118_MxR_thirdbatch_DSSOplate_D7_D8	proteomic profiling by mass spectrometry	L1_20211118_MxR_thirdbatch_DSSOplate_D7_D8.raw	1	14	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch3	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	3	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211118_MxR_thirdbatch_DSSOplate_D9_D10	proteomic profiling by mass spectrometry	L1_20211118_MxR_thirdbatch_DSSOplate_D9_D10.raw	1	15	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch3	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	3	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211118_MxR_thirdbatch_DSSOplate_E11_E12	proteomic profiling by mass spectrometry	L1_20211118_MxR_thirdbatch_DSSOplate_E11_E12.raw	1	16	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch3	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	3	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211118_MxR_thirdbatch_DSSOplate_E1_E2	proteomic profiling by mass spectrometry	L1_20211118_MxR_thirdbatch_DSSOplate_E1_E2.raw	1	17	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch3	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	3	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211118_MxR_thirdbatch_DSSOplate_E3_E4_212733	proteomic profiling by mass spectrometry	L1_20211118_MxR_thirdbatch_DSSOplate_E3_E4_212733.raw	1	18	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch3	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	3	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211118_MxR_thirdbatch_DSSOplate_E5_E6	proteomic profiling by mass spectrometry	L1_20211118_MxR_thirdbatch_DSSOplate_E5_E6.raw	1	19	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch3	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	3	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211118_MxR_thirdbatch_DSSOplate_E7_E8	proteomic profiling by mass spectrometry	L1_20211118_MxR_thirdbatch_DSSOplate_E7_E8.raw	1	20	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch3	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	3	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211118_MxR_thirdbatch_DSSOplate_E9_E10	proteomic profiling by mass spectrometry	L1_20211118_MxR_thirdbatch_DSSOplate_E9_E10.raw	1	21	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch3	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	3	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211118_MxR_thirdbatch_DSSOplate_F1_F2	proteomic profiling by mass spectrometry	L1_20211118_MxR_thirdbatch_DSSOplate_F1_F2.raw	1	22	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch3	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	3	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211118_MxR_thirdbatch_DSSOplate_F3_F4	proteomic profiling by mass spectrometry	L1_20211118_MxR_thirdbatch_DSSOplate_F3_F4.raw	1	23	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch3	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	3	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20211118_MxR_thirdbatch_DSSOplate_F5_F6	proteomic profiling by mass spectrometry	L1_20211118_MxR_thirdbatch_DSSOplate_F5_F6.raw	1	24	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch4	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	4	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20220110_MxR_FDR_fourthbatch_DSSOplate_B11_B12	proteomic profiling by mass spectrometry	L1_20220110_MxR_FDR_fourthbatch_DSSOplate_B11_B12.raw	1	1	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch4	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	4	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20220110_MxR_FDR_fourthbatch_DSSOplate_B1_B2	proteomic profiling by mass spectrometry	L1_20220110_MxR_FDR_fourthbatch_DSSOplate_B1_B2.raw	1	2	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch4	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	4	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20220110_MxR_FDR_fourthbatch_DSSOplate_B3_B4	proteomic profiling by mass spectrometry	L1_20220110_MxR_FDR_fourthbatch_DSSOplate_B3_B4.raw	1	3	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch4	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	4	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20220110_MxR_FDR_fourthbatch_DSSOplate_B5_B6	proteomic profiling by mass spectrometry	L1_20220110_MxR_FDR_fourthbatch_DSSOplate_B5_B6.raw	1	4	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch4	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	4	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20220110_MxR_FDR_fourthbatch_DSSOplate_B7_B8	proteomic profiling by mass spectrometry	L1_20220110_MxR_FDR_fourthbatch_DSSOplate_B7_B8.raw	1	5	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch4	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	4	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20220110_MxR_FDR_fourthbatch_DSSOplate_B9_B10	proteomic profiling by mass spectrometry	L1_20220110_MxR_FDR_fourthbatch_DSSOplate_B9_B10.raw	1	6	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch4	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	4	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20220110_MxR_FDR_fourthbatch_DSSOplate_C11_C12	proteomic profiling by mass spectrometry	L1_20220110_MxR_FDR_fourthbatch_DSSOplate_C11_C12.raw	1	7	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch4	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	4	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20220110_MxR_FDR_fourthbatch_DSSOplate_C1_C2	proteomic profiling by mass spectrometry	L1_20220110_MxR_FDR_fourthbatch_DSSOplate_C1_C2.raw	1	8	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch4	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	4	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20220110_MxR_FDR_fourthbatch_DSSOplate_C3_C4	proteomic profiling by mass spectrometry	L1_20220110_MxR_FDR_fourthbatch_DSSOplate_C3_C4.raw	1	9	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch4	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	4	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20220110_MxR_FDR_fourthbatch_DSSOplate_C5_C6	proteomic profiling by mass spectrometry	L1_20220110_MxR_FDR_fourthbatch_DSSOplate_C5_C6.raw	1	10	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch4	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	4	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20220110_MxR_FDR_fourthbatch_DSSOplate_C7_C8	proteomic profiling by mass spectrometry	L1_20220110_MxR_FDR_fourthbatch_DSSOplate_C7_C8.raw	1	11	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch4	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	4	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20220110_MxR_FDR_fourthbatch_DSSOplate_C9_C10	proteomic profiling by mass spectrometry	L1_20220110_MxR_FDR_fourthbatch_DSSOplate_C9_C10.raw	1	12	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch4	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	4	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20220110_MxR_FDR_fourthbatch_DSSOplate_D11_D12	proteomic profiling by mass spectrometry	L1_20220110_MxR_FDR_fourthbatch_DSSOplate_D11_D12.raw	1	13	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch4	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	4	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20220110_MxR_FDR_fourthbatch_DSSOplate_D1_D2	proteomic profiling by mass spectrometry	L1_20220110_MxR_FDR_fourthbatch_DSSOplate_D1_D2.raw	1	14	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch4	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	4	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20220110_MxR_FDR_fourthbatch_DSSOplate_D3_D4	proteomic profiling by mass spectrometry	L1_20220110_MxR_FDR_fourthbatch_DSSOplate_D3_D4.raw	1	15	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch4	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	4	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20220110_MxR_FDR_fourthbatch_DSSOplate_D5_D6	proteomic profiling by mass spectrometry	L1_20220110_MxR_FDR_fourthbatch_DSSOplate_D5_D6.raw	1	16	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch4	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	4	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20220110_MxR_FDR_fourthbatch_DSSOplate_D7_D8	proteomic profiling by mass spectrometry	L1_20220110_MxR_FDR_fourthbatch_DSSOplate_D7_D8.raw	1	17	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch4	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	4	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20220110_MxR_FDR_fourthbatch_DSSOplate_D9_D10	proteomic profiling by mass spectrometry	L1_20220110_MxR_FDR_fourthbatch_DSSOplate_D9_D10.raw	1	18	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch4	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	4	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20220110_MxR_FDR_fourthbatch_DSSOplate_E7_E8	proteomic profiling by mass spectrometry	L1_20220110_MxR_FDR_fourthbatch_DSSOplate_E7_E8.raw	1	19	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch4	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	4	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20220118_MxR_FDR_fourthbatch_DSSOplate_E11_E12_remeasure	proteomic profiling by mass spectrometry	L1_20220118_MxR_FDR_fourthbatch_DSSOplate_E11_E12_remeasure.raw	1	20	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch4	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	4	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20220118_MxR_FDR_fourthbatch_DSSOplate_E1_E2_remeasure3	proteomic profiling by mass spectrometry	L1_20220118_MxR_FDR_fourthbatch_DSSOplate_E1_E2_remeasure3.raw	1	21	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch4	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	4	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20220118_MxR_FDR_fourthbatch_DSSOplate_E3_E4_remeasure2	proteomic profiling by mass spectrometry	L1_20220118_MxR_FDR_fourthbatch_DSSOplate_E3_E4_remeasure2.raw	1	22	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch4	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	4	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20220118_MxR_FDR_fourthbatch_DSSOplate_E5_E6_remeasure	proteomic profiling by mass spectrometry	L1_20220118_MxR_FDR_fourthbatch_DSSOplate_E5_E6_remeasure.raw	1	23	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch4	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	4	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20220118_MxR_FDR_fourthbatch_DSSOplate_E9_E10_remeasure	proteomic profiling by mass spectrometry	L1_20220118_MxR_FDR_fourthbatch_DSSOplate_E9_E10_remeasure.raw	1	24	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch4	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	4	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20220118_MxR_FDR_fourthbatch_DSSOplate_F11_F12_remeasure	proteomic profiling by mass spectrometry	L1_20220118_MxR_FDR_fourthbatch_DSSOplate_F11_F12_remeasure.raw	1	25	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch4	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	4	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20220118_MxR_FDR_fourthbatch_DSSOplate_F1_F2_remeasure	proteomic profiling by mass spectrometry	L1_20220118_MxR_FDR_fourthbatch_DSSOplate_F1_F2_remeasure.raw	1	26	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch4	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	4	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20220118_MxR_FDR_fourthbatch_DSSOplate_F3_F4_remeasure	proteomic profiling by mass spectrometry	L1_20220118_MxR_FDR_fourthbatch_DSSOplate_F3_F4_remeasure.raw	1	27	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch4	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	4	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20220118_MxR_FDR_fourthbatch_DSSOplate_F5_F6_remeasure	proteomic profiling by mass spectrometry	L1_20220118_MxR_FDR_fourthbatch_DSSOplate_F5_F6_remeasure.raw	1	28	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch4	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	4	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20220118_MxR_FDR_fourthbatch_DSSOplate_F7_F8_remeasure	proteomic profiling by mass spectrometry	L1_20220118_MxR_FDR_fourthbatch_DSSOplate_F7_F8_remeasure.raw	1	29	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch4	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	4	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20220118_MxR_FDR_fourthbatch_DSSOplate_F9_F10_remeasure	proteomic profiling by mass spectrometry	L1_20220118_MxR_FDR_fourthbatch_DSSOplate_F9_F10_remeasure.raw	1	30	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch4	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	4	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20220118_MxR_FDR_fourthbatch_DSSOplate_G1_G2_remeasure	proteomic profiling by mass spectrometry	L1_20220118_MxR_FDR_fourthbatch_DSSOplate_G1_G2_remeasure.raw	1	31	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch5	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	5	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20240412_MxR_FDR_fifthbatch_DSSO_B11_B12	proteomic profiling by mass spectrometry	L1_20240412_MxR_FDR_fifthbatch_DSSO_B11_B12.raw	1	1	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch5	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	5	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20240412_MxR_FDR_fifthbatch_DSSO_B1_B2	proteomic profiling by mass spectrometry	L1_20240412_MxR_FDR_fifthbatch_DSSO_B1_B2.raw	1	2	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch5	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	5	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20240412_MxR_FDR_fifthbatch_DSSO_B3_B4	proteomic profiling by mass spectrometry	L1_20240412_MxR_FDR_fifthbatch_DSSO_B3_B4.raw	1	3	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch5	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	5	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20240412_MxR_FDR_fifthbatch_DSSO_B5_B6	proteomic profiling by mass spectrometry	L1_20240412_MxR_FDR_fifthbatch_DSSO_B5_B6.raw	1	4	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch5	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	5	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20240412_MxR_FDR_fifthbatch_DSSO_B7_B8	proteomic profiling by mass spectrometry	L1_20240412_MxR_FDR_fifthbatch_DSSO_B7_B8.raw	1	5	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch5	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	5	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20240412_MxR_FDR_fifthbatch_DSSO_B9_B10	proteomic profiling by mass spectrometry	L1_20240412_MxR_FDR_fifthbatch_DSSO_B9_B10.raw	1	6	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch5	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	5	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20240412_MxR_FDR_fifthbatch_DSSO_C1	proteomic profiling by mass spectrometry	L1_20240412_MxR_FDR_fifthbatch_DSSO_C1.raw	1	7	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch5	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	5	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20240412_MxR_FDR_fifthbatch_DSSO_C10	proteomic profiling by mass spectrometry	L1_20240412_MxR_FDR_fifthbatch_DSSO_C10.raw	1	8	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch5	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	5	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20240412_MxR_FDR_fifthbatch_DSSO_C11	proteomic profiling by mass spectrometry	L1_20240412_MxR_FDR_fifthbatch_DSSO_C11.raw	1	9	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch5	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	5	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20240412_MxR_FDR_fifthbatch_DSSO_C12	proteomic profiling by mass spectrometry	L1_20240412_MxR_FDR_fifthbatch_DSSO_C12.raw	1	10	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch5	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	5	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20240412_MxR_FDR_fifthbatch_DSSO_C2	proteomic profiling by mass spectrometry	L1_20240412_MxR_FDR_fifthbatch_DSSO_C2.raw	1	11	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch5	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	5	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20240412_MxR_FDR_fifthbatch_DSSO_C3	proteomic profiling by mass spectrometry	L1_20240412_MxR_FDR_fifthbatch_DSSO_C3.raw	1	12	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch5	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	5	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20240412_MxR_FDR_fifthbatch_DSSO_C4	proteomic profiling by mass spectrometry	L1_20240412_MxR_FDR_fifthbatch_DSSO_C4.raw	1	13	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch5	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	5	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20240412_MxR_FDR_fifthbatch_DSSO_C5	proteomic profiling by mass spectrometry	L1_20240412_MxR_FDR_fifthbatch_DSSO_C5.raw	1	14	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch5	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	5	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20240412_MxR_FDR_fifthbatch_DSSO_C6	proteomic profiling by mass spectrometry	L1_20240412_MxR_FDR_fifthbatch_DSSO_C6.raw	1	15	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch5	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	5	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20240412_MxR_FDR_fifthbatch_DSSO_C7	proteomic profiling by mass spectrometry	L1_20240412_MxR_FDR_fifthbatch_DSSO_C7.raw	1	16	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch5	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	5	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20240412_MxR_FDR_fifthbatch_DSSO_C8	proteomic profiling by mass spectrometry	L1_20240412_MxR_FDR_fifthbatch_DSSO_C8.raw	1	17	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch5	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	5	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20240412_MxR_FDR_fifthbatch_DSSO_C9	proteomic profiling by mass spectrometry	L1_20240412_MxR_FDR_fifthbatch_DSSO_C9.raw	1	18	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch5	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	5	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20240412_MxR_FDR_fifthbatch_DSSO_D1	proteomic profiling by mass spectrometry	L1_20240412_MxR_FDR_fifthbatch_DSSO_D1.raw	1	19	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch5	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	5	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20240412_MxR_FDR_fifthbatch_DSSO_D10	proteomic profiling by mass spectrometry	L1_20240412_MxR_FDR_fifthbatch_DSSO_D10.raw	1	20	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch5	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	5	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20240412_MxR_FDR_fifthbatch_DSSO_D11	proteomic profiling by mass spectrometry	L1_20240412_MxR_FDR_fifthbatch_DSSO_D11.raw	1	21	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch5	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	5	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20240412_MxR_FDR_fifthbatch_DSSO_D12	proteomic profiling by mass spectrometry	L1_20240412_MxR_FDR_fifthbatch_DSSO_D12.raw	1	22	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch5	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	5	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20240412_MxR_FDR_fifthbatch_DSSO_D2	proteomic profiling by mass spectrometry	L1_20240412_MxR_FDR_fifthbatch_DSSO_D2.raw	1	23	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch5	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	5	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20240412_MxR_FDR_fifthbatch_DSSO_D3	proteomic profiling by mass spectrometry	L1_20240412_MxR_FDR_fifthbatch_DSSO_D3.raw	1	24	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch5	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	5	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20240412_MxR_FDR_fifthbatch_DSSO_D4	proteomic profiling by mass spectrometry	L1_20240412_MxR_FDR_fifthbatch_DSSO_D4.raw	1	25	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch5	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	5	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20240412_MxR_FDR_fifthbatch_DSSO_D5	proteomic profiling by mass spectrometry	L1_20240412_MxR_FDR_fifthbatch_DSSO_D5.raw	1	26	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch5	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	5	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20240412_MxR_FDR_fifthbatch_DSSO_D6	proteomic profiling by mass spectrometry	L1_20240412_MxR_FDR_fifthbatch_DSSO_D6.raw	1	27	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch5	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	5	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20240412_MxR_FDR_fifthbatch_DSSO_D7	proteomic profiling by mass spectrometry	L1_20240412_MxR_FDR_fifthbatch_DSSO_D7.raw	1	28	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch5	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	5	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20240412_MxR_FDR_fifthbatch_DSSO_D8	proteomic profiling by mass spectrometry	L1_20240412_MxR_FDR_fifthbatch_DSSO_D8.raw	1	29	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch5	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	5	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20240412_MxR_FDR_fifthbatch_DSSO_D9	proteomic profiling by mass spectrometry	L1_20240412_MxR_FDR_fifthbatch_DSSO_D9.raw	1	30	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch5	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	5	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20240412_MxR_FDR_fifthbatch_DSSO_E11_E12	proteomic profiling by mass spectrometry	L1_20240412_MxR_FDR_fifthbatch_DSSO_E11_E12.raw	1	31	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch5	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	5	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20240412_MxR_FDR_fifthbatch_DSSO_E1_E2	proteomic profiling by mass spectrometry	L1_20240412_MxR_FDR_fifthbatch_DSSO_E1_E2.raw	1	32	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch5	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	5	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20240412_MxR_FDR_fifthbatch_DSSO_E3_E4	proteomic profiling by mass spectrometry	L1_20240412_MxR_FDR_fifthbatch_DSSO_E3_E4.raw	1	33	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch5	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	5	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20240412_MxR_FDR_fifthbatch_DSSO_E5_E6	proteomic profiling by mass spectrometry	L1_20240412_MxR_FDR_fifthbatch_DSSO_E5_E6.raw	1	34	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch5	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	5	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20240412_MxR_FDR_fifthbatch_DSSO_E7_E8	proteomic profiling by mass spectrometry	L1_20240412_MxR_FDR_fifthbatch_DSSO_E7_E8.raw	1	35	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch5	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	5	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20240412_MxR_FDR_fifthbatch_DSSO_E9_E10	proteomic profiling by mass spectrometry	L1_20240412_MxR_FDR_fifthbatch_DSSO_E9_E10.raw	1	36	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch5	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	5	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20240412_MxR_FDR_fifthbatch_DSSO_F11_F12	proteomic profiling by mass spectrometry	L1_20240412_MxR_FDR_fifthbatch_DSSO_F11_F12.raw	1	37	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch5	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	5	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20240412_MxR_FDR_fifthbatch_DSSO_F1_F2	proteomic profiling by mass spectrometry	L1_20240412_MxR_FDR_fifthbatch_DSSO_F1_F2.raw	1	38	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch5	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	5	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20240412_MxR_FDR_fifthbatch_DSSO_F3_F4	proteomic profiling by mass spectrometry	L1_20240412_MxR_FDR_fifthbatch_DSSO_F3_F4.raw	1	39	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch5	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	5	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20240412_MxR_FDR_fifthbatch_DSSO_F5_F6	proteomic profiling by mass spectrometry	L1_20240412_MxR_FDR_fifthbatch_DSSO_F5_F6.raw	1	40	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch5	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	5	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20240412_MxR_FDR_fifthbatch_DSSO_F7_F8	proteomic profiling by mass spectrometry	L1_20240412_MxR_FDR_fifthbatch_DSSO_F7_F8.raw	1	41	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch5	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	5	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20240412_MxR_FDR_fifthbatch_DSSO_F9_F10	proteomic profiling by mass spectrometry	L1_20240412_MxR_FDR_fifthbatch_DSSO_F9_F10.raw	1	42	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch5	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	5	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20240412_MxR_FDR_fifthbatch_DSSO_G11_G12	proteomic profiling by mass spectrometry	L1_20240412_MxR_FDR_fifthbatch_DSSO_G11_G12.raw	1	43	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch5	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	5	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20240412_MxR_FDR_fifthbatch_DSSO_G1_G2	proteomic profiling by mass spectrometry	L1_20240412_MxR_FDR_fifthbatch_DSSO_G1_G2.raw	1	44	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch5	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	5	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20240412_MxR_FDR_fifthbatch_DSSO_G3_G4	proteomic profiling by mass spectrometry	L1_20240412_MxR_FDR_fifthbatch_DSSO_G3_G4.raw	1	45	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch5	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	5	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20240412_MxR_FDR_fifthbatch_DSSO_G5_G6	proteomic profiling by mass spectrometry	L1_20240412_MxR_FDR_fifthbatch_DSSO_G5_G6.raw	1	46	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch5	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	5	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20240412_MxR_FDR_fifthbatch_DSSO_G7_G8	proteomic profiling by mass spectrometry	L1_20240412_MxR_FDR_fifthbatch_DSSO_G7_G8.raw	1	47	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
+PXD042173-batch5	homo sapiens	not applicable	not applicable	not applicable	not available	not applicable	5	synthetic	reference	enrichment of cross-linked peptides	26.4 Å	30 min	room temperature	L1_20240412_MxR_FDR_fifthbatch_DSSO_G9_G10	proteomic profiling by mass spectrometry	L1_20240412_MxR_FDR_fifthbatch_DSSO_G9_G10.raw	1	48	AC=MS:1002038;NT=label free sample	NT=Orbitrap Fusion Lumos;AC=MS:1002732	NT=Data-dependent acquisition;AC=PRIDE:0000449	NT=Trypsin;AC=MS:1001251	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;AC=UNIMOD:35;TA=M;MT=Variable	NT=stepped HCD;AC=PRIDE:0000590	stepped 27+-6%	10 ppm	20 ppm	NT=strong cation exchange chromatography;AC=PRIDE:0000586	cross-linking mass spectrometry	NT=DSSO;AC=XLMOD:02010;CL=yes;TA=K,S,T,Y,nterm;MH=54.01;ML=85.98	strong cation exchange chromatography	0.2-1 mM	Tris-HCl	NT=dithiothreitol;AC=CHEBI:18320	NT=chloroacetamide;AC=CHEBI:27869	v1.1.0	NT=ms-proteomics;VV=v1.1.0	NT=crosslinking;VV=v1.0.0	NT=human;VV=v1.1.0
diff --git a/psi-document/sdrf-proteomics-specification-v1.1.0-dev.pdf b/psi-document/sdrf-proteomics-specification-v1.1.0-dev.pdf
index 644c8f39..bd923d34 100644
Binary files a/psi-document/sdrf-proteomics-specification-v1.1.0-dev.pdf and b/psi-document/sdrf-proteomics-specification-v1.1.0-dev.pdf differ
diff --git a/scripts/inject-headers.py b/scripts/inject-headers.py
index 5c36fd1a..096c44c3 100755
--- a/scripts/inject-headers.py
+++ b/scripts/inject-headers.py
@@ -38,11 +38,11 @@ def inject_header(filepath: str, header_html: str, is_dev: bool = False) -> None
     with open(filepath, 'r', encoding='utf-8') as f:
         content = f.read()
 
-    # Resolve version link based on dev/stable mode
+    # Resolve version link: only show in dev builds (link back to stable)
     if is_dev:
         version_link = '<a href="/" class="version-link">Stable Version</a>'
     else:
-        version_link = '<a href="/dev/" class="version-link">Dev Version</a>'
+        version_link = ''
     resolved_header = header_html.replace(VERSION_LINK_PLACEHOLDER, version_link)
 
     # Add has-doc-header class to body
@@ -56,17 +56,24 @@ def inject_header(filepath: str, header_html: str, is_dev: bool = False) -> None
         f.write(content)
 
 
-def rewrite_version_links(filepath: str, is_dev: bool) -> None:
-    """Rewrite version links in static HTML pages (index.html, quickstart.html, etc.)."""
+def inject_version_link_into_static(filepath: str, is_dev: bool) -> None:
+    """Inject a 'Stable Version' link into static HTML pages for dev builds."""
+    if not is_dev:
+        return  # Stable builds don't show a version link
+
     with open(filepath, 'r', encoding='utf-8') as f:
         content = f.read()
 
-    if is_dev:
-        content = content.replace(
-            '<a href="/dev/" class="version-link">Dev Version</a>',
-            '<a href="/" class="version-link">Stable Version</a>'
-        )
-    # No change needed for stable — the source files already have /dev/ links
+    # Already has a version link — skip
+    if 'class="version-link"' in content:
+        return
+
+    # Insert "Stable Version" link before the GitHub link
+    stable_link = '<a href="/" class="version-link">Stable Version</a>'
+    content = content.replace(
+        '<a href="https://github.com/bigbio/proteomics-metadata-standard"',
+        stable_link + '<a href="https://github.com/bigbio/proteomics-metadata-standard"'
+    )
 
     with open(filepath, 'w', encoding='utf-8') as f:
         f.write(content)
@@ -120,13 +127,13 @@ def main():
             print(f"Injecting header into: {html_file}")
             inject_header(str(html_file), HEADERS['templates'], is_dev)
 
-    # Rewrite version links in static HTML pages (index.html, quickstart.html, etc.)
+    # Inject version link into static HTML pages for dev builds
     for static_page in ["index.html", "quickstart.html", "sdrf-terms.html",
                          "sdrf-explorer.html", "sdrf-editor.html", "sdrf-builder.html"]:
         static_file = output_dir / static_page
         if static_file.exists():
-            print(f"Rewriting version links in: {static_file}")
-            rewrite_version_links(str(static_file), is_dev)
+            print(f"Processing version link in: {static_file}")
+            inject_version_link_into_static(str(static_file), is_dev)
 
     print("Header injection complete!")
 
diff --git a/site/js/sdrf-builder.js b/site/js/sdrf-builder.js
index ad995197..27288a27 100644
--- a/site/js/sdrf-builder.js
+++ b/site/js/sdrf-builder.js
@@ -45,6 +45,7 @@
         affinitySubtype: null,
         extraColumns: [],      // columns from sdrf-terms.tsv added by user
         addedOptionals: [],    // optional template columns the user opted into
+        removedColumns: [],    // recommended columns the user explicitly removed
         factorValues: []       // characteristics chosen as factor values
     };
 
@@ -180,6 +181,9 @@
             if (req === 'optional') {
                 // Only include if user explicitly added it
                 if (state.addedOptionals.indexOf(colName) === -1) continue;
+            } else if (req === 'recommended') {
+                // Exclude if user explicitly removed it
+                if (state.removedColumns.indexOf(colName) !== -1) continue;
             }
             result.push(col2);
         }
@@ -380,6 +384,7 @@
         state.experiments = [];
         state.affinitySubtype = null;
         state.addedOptionals = [];
+        state.removedColumns = [];
         state.extraColumns = [];
         state.factorValues = [];
 
@@ -608,8 +613,9 @@
                 continue;
             }
 
-            if (req === 'optional' && !includedNames[colName]) {
-                // Optional and not enabled -> goes in "optional" section
+            if ((req === 'optional' && !includedNames[colName]) ||
+                (req === 'recommended' && state.removedColumns.indexOf(colName) !== -1)) {
+                // Optional not enabled, or recommended that user removed -> "optional" section
                 optionalCols.push(col);
             } else if (includedNames[colName] && state.extraColumns.indexOf(colName) === -1) {
                 // Included from template (not user-added extra)
@@ -734,7 +740,14 @@
                     item.appendChild(toggleBtn);
 
                     item.addEventListener('click', function () {
-                        state.addedOptionals.push(col.name);
+                        var req = col.requirement || 'optional';
+                        if (req === 'recommended') {
+                            // Re-add: remove from removedColumns
+                            var idx = state.removedColumns.indexOf(col.name);
+                            if (idx !== -1) state.removedColumns.splice(idx, 1);
+                        } else {
+                            state.addedOptionals.push(col.name);
+                        }
                         updatePreview();
                     });
                     optDiv.appendChild(item);
@@ -844,6 +857,11 @@
                     // Remove from extra
                     var idx = state.extraColumns.indexOf(colName);
                     if (idx !== -1) state.extraColumns.splice(idx, 1);
+                } else if (col.requirement === 'recommended') {
+                    // Move recommended column to removed list
+                    if (state.removedColumns.indexOf(colName) === -1) {
+                        state.removedColumns.push(colName);
+                    }
                 } else {
                     // Toggle optional template column off (remove from addedOptionals)
                     var idx2 = state.addedOptionals.indexOf(colName);
@@ -896,11 +914,16 @@
         var columns = resolveColumns();
         if (!columns.length) return;
 
-        var names = [];
+        var headers = [];
+        var values = [];
         for (var i = 0; i < columns.length; i++) {
-            names.push(columns[i].name);
+            headers.push(columns[i].name);
+            values.push(columns[i].example_value || '');
         }
-        window.open('sdrf-editor.html?columns=' + encodeURIComponent(names.join(',')));
+
+        var tsv = headers.join('\t') + '\n' + values.join('\t') + '\n';
+        var encoded = btoa(unescape(encodeURIComponent(tsv)));
+        window.open('sdrf-editor.html?content=' + encodeURIComponent(encoded));
     }
 
     /* ---------------------------------------------------------------
diff --git a/site/quickstart.html b/site/quickstart.html
index 3f89000e..e823eefe 100644
--- a/site/quickstart.html
+++ b/site/quickstart.html
@@ -109,7 +109,6 @@
                 <a href="./sdrf-explorer.html">Explorer</a>
                 <a href="./sdrf-editor.html">Editor</a>
                 <a href="./quickstart.html" class="nav-current">Quick Start</a>
-                <a href="/dev/" class="version-link">Dev Version</a>
                 <a href="https://github.com/bigbio/proteomics-metadata-standard" target="_blank">GitHub</a>
             </nav>
         </div>
diff --git a/site/sdrf-builder.html b/site/sdrf-builder.html
index 86cc604d..f896e2a2 100644
--- a/site/sdrf-builder.html
+++ b/site/sdrf-builder.html
@@ -17,7 +17,6 @@
                 <a href="./index.html#tools">Tools</a>
                 <a href="./sdrf-explorer.html">Explorer</a>
                 <a href="./sdrf-editor.html">Editor</a>
-                <a href="/dev/" class="version-link">Dev Version</a>
                 <a href="https://github.com/bigbio/proteomics-metadata-standard" target="_blank">GitHub</a>
             </nav>
         </div>
diff --git a/site/sdrf-data.json b/site/sdrf-data.json
index 65c2639a..7bdd4c6f 100644
--- a/site/sdrf-data.json
+++ b/site/sdrf-data.json
@@ -2,7 +2,7 @@
   "statistics": {
     "total_datasets": 298,
     "total_samples": 80289,
-    "generated_at": "2026-03-09T10:31:23.858864Z",
+    "generated_at": "2026-03-09T20:18:10.203334Z",
     "organisms": {
       "Homo sapiens": 51421,
       "homo sapiens": 10167,
@@ -301,9 +301,9 @@
       "no cleavage": 5
     },
     "experiment_types": {
-      "DDA": 291,
+      "DDA": 290,
       "SRM/MRM": 3,
-      "DIA": 4
+      "DIA": 5
     },
     "label_types": {
       "Label-free": 229,
@@ -329,13 +329,13 @@
         "Homo sapiens"
       ],
       "diseases": [
-        "non-small cell lung cancer",
-        "small cell lung cancer"
+        "small cell lung cancer",
+        "non-small cell lung cancer"
       ],
       "instruments": [
         "Orbitrap Elite",
-        "LTQ Orbitrap Velos",
-        " Orbitrap Fusion Lumos"
+        " Orbitrap Fusion Lumos",
+        "LTQ Orbitrap Velos"
       ],
       "acquisition_methods": [
         "Data-dependent acquisition"
@@ -355,8 +355,8 @@
       "num_samples": 96,
       "num_columns": 35,
       "organisms": [
-        "homo sapiens",
-        "mus musculus"
+        "mus musculus",
+        "homo sapiens"
       ],
       "diseases": [
         "melanoma"
@@ -438,12 +438,12 @@
         "homo sapiens"
       ],
       "diseases": [
-        "monoclonal gammopathy",
-        "multiple myeloma"
+        "multiple myeloma",
+        "monoclonal gammopathy"
       ],
       "instruments": [
-        "Orbitrap Elite",
-        "LTQ Orbitrap XL"
+        "LTQ Orbitrap XL",
+        "Orbitrap Elite"
       ],
       "acquisition_methods": [
         "Data-dependent acquisition"
@@ -516,8 +516,8 @@
       "diseases": [
         "Rectal Adenocarcinoma",
         "Rectal Mucinous Adenocarcinoma",
-        "Colon Mucinous Adenocarcinoma",
-        "Colon Adenocarcinoma"
+        "Colon Adenocarcinoma",
+        "Colon Mucinous Adenocarcinoma"
       ],
       "instruments": [
         "LTQ Orbitrap Velos"
@@ -595,8 +595,8 @@
         "Homo sapiens"
       ],
       "diseases": [
-        "Non-Tumor",
-        "ovarian high grade serous adenocarcinoma"
+        "ovarian high grade serous adenocarcinoma",
+        "Non-Tumor"
       ],
       "instruments": [
         "Q Exactive"
@@ -847,8 +847,8 @@
         "Homo sapiens"
       ],
       "diseases": [
-        "heart infarction",
         "cardiopulmonary insufficiency",
+        "heart infarction",
         "lung embolism"
       ],
       "instruments": [
@@ -875,8 +875,8 @@
         "Homo sapiens"
       ],
       "diseases": [
-        "heart infarction",
         "cardiopulmonary insufficiency",
+        "heart infarction",
         "lung embolism"
       ],
       "instruments": [
@@ -1868,11 +1868,11 @@
         "Homo sapiens"
       ],
       "diseases": [
-        "Mlignant Melanoma",
-        "Breast Adenocarcinoma",
-        "Glioblastoma",
+        "Pancreatic Carcinoma",
         "Breast Cancer",
-        "Pancreatic Carcinoma"
+        "Breast Adenocarcinoma",
+        "Mlignant Melanoma",
+        "Glioblastoma"
       ],
       "instruments": [
         "LTQ Orbitrap Velos"
@@ -1998,16 +1998,16 @@
         "Homo sapiens"
       ],
       "diseases": [
-        "Chronic myelogenous leukemia, BCR-ABL1 positive",
-        "Prostate carcinoma",
-        "Lung adenocarcinoma",
+        "Osteosarcoma",
+        "Hepatoblastoma",
         "Human papillomavirus-related endocervical adenocarcinoma",
+        "Lung adenocarcinoma",
+        "Prostate carcinoma",
         "Glioblastoma",
-        "Hepatoblastoma",
+        "Chronic myelogenous leukemia, BCR-ABL1 positive",
         "Childhood T acute lymphoblastic leukemia",
-        "Colon carcinoma",
-        "Osteosarcoma",
-        "Invasive ductal carcinoma, not otherwise specified"
+        "Invasive ductal carcinoma, not otherwise specified",
+        "Colon carcinoma"
       ],
       "instruments": [
         "LTQ Orbitrap Velos"
@@ -2180,8 +2180,8 @@
         "Homo sapiens"
       ],
       "diseases": [
-        "Prostate adenocarcinoma",
-        "control"
+        "control",
+        "Prostate adenocarcinoma"
       ],
       "instruments": [
         "Q Exactive"
@@ -2207,8 +2207,8 @@
         "Homo sapiens"
       ],
       "diseases": [
-        "Prostate adenocarcinoma",
-        "control"
+        "control",
+        "Prostate adenocarcinoma"
       ],
       "instruments": [
         "Q Exactive"
@@ -2234,27 +2234,27 @@
         "Homo sapiens"
       ],
       "diseases": [
+        "Anaplastic large cell lymphoma",
+        "Primary mediastinal large B-cell lymphoma",
+        "Diffuse large B-cell lymphoma",
+        "lymphoma",
+        "Sezary Syndrome",
+        "Nodular lymphocyte predominant Hodgkin lymphoma",
         "acute T cell leukemia",
         "Multiple Myeloma",
-        "Diffuse large B-cell lymphoma",
+        "Burkitt's lymphoma",
+        "Classical Hodgkin lymphoma",
         "diffuse histiocytic lymphoma",
         "Mantle cell lymphoma",
-        "Nodular lymphocyte predominant Hodgkin lymphoma",
-        "malignant non-Hodgkin's lymphoma",
-        "Burkitt's lymphoma (American)",
+        "Aggressive NK-cell leukemia",
         "Burkitt lymphoma",
-        "follicular lymphoma",
-        "Burkitt's lymphoma",
-        "Anaplastic large cell lymphoma,",
-        "Primary mediastinal large B-cell lymphoma",
-        "Classical Hodgkin lymphoma",
-        "cutaneous T cell lymphoma",
-        "lymphoma",
         "Transformed follicular lymphoma",
+        "Anaplastic large cell lymphoma,",
+        "follicular lymphoma",
+        "malignant non-Hodgkin's lymphoma",
         "plasmacytoma",
-        "Aggressive NK-cell leukemia",
-        "Anaplastic large cell lymphoma",
-        "Sezary Syndrome"
+        "Burkitt's lymphoma (American)",
+        "cutaneous T cell lymphoma"
       ],
       "instruments": [
         "LTQ Orbitrap XL"
@@ -2280,8 +2280,8 @@
         "Homo sapiens"
       ],
       "diseases": [
-        "Prostate adenocarcinoma",
-        "control"
+        "control",
+        "Prostate adenocarcinoma"
       ],
       "instruments": [
         "Q Exactive"
@@ -2307,8 +2307,8 @@
         "Homo sapiens"
       ],
       "diseases": [
-        "high grade serous ovarian cancer",
-        "epithelial ovarian cancer"
+        "epithelial ovarian cancer",
+        "high grade serous ovarian cancer"
       ],
       "instruments": [
         "Q Exactive HF-X",
@@ -2336,36 +2336,36 @@
       ],
       "diseases": [
         "clear cell renal carcinoma",
-        "malignant melanoma",
-        "promyelocytic leukemia",
-        "melanoma",
-        "ovarian adenocarcinoma",
-        "skin cutaneous melanoma",
-        "renal clear cell adenocarcinoma",
-        "renal carcinoma",
-        "acute lymphoblastic leukemia",
-        "glioblastoma",
-        "breast ductal adenocarcinoma",
+        "colon carcinoma",
+        "acute T lymphoblastic leukaemia",
+        "prostate adenocarcinoma",
+        "breast carcinoma",
+        "renal adenocarcinoma",
+        "ovarian serous cystadenocarcinoma",
+        "renal cell adenocarcinoma",
         "large cell lung carcinoma",
+        "renal carcinoma",
         "astrocytoma",
+        "non-small cell lung carcinoma",
+        "glioma",
+        "malignant melanoma",
         "chronic myelogenic leukemia",
-        "ovarian serous cystadenocarcinoma",
-        "renal cell carcinoma",
-        "breast adenocarcinoma",
-        "renal adenocarcinoma",
         "mesothelioma",
-        "non-small cell lung carcinoma",
-        "renal cell adenocarcinoma",
         "ovarian carcinoma",
-        "prostate adenocarcinoma",
-        "acute T lymphoblastic leukaemia",
+        "breast adenocarcinoma",
+        "acute lymphoblastic leukemia",
+        "immunoblastic large cell lymphoma",
+        "promyelocytic leukemia",
         "lung carcinoma",
-        "breast carcinoma",
+        "colon adenocarcinoma",
+        "renal cell carcinoma",
+        "ovarian adenocarcinoma",
         "plasmacytoma",
-        "colon carcinoma",
-        "immunoblastic large cell lymphoma",
-        "glioma",
-        "colon adenocarcinoma"
+        "glioblastoma",
+        "breast ductal adenocarcinoma",
+        "melanoma",
+        "renal clear cell adenocarcinoma",
+        "skin cutaneous melanoma"
       ],
       "instruments": [
         "TripleTOF 5600"
@@ -2417,8 +2417,8 @@
         "Homo sapiens"
       ],
       "diseases": [
-        "Prostate adenocarcinoma",
-        "control"
+        "control",
+        "Prostate adenocarcinoma"
       ],
       "instruments": [
         "Q Exactive"
@@ -2496,8 +2496,8 @@
         "Homo sapiens"
       ],
       "diseases": [
-        "Prostate adenocarcinoma",
-        "control"
+        "control",
+        "Prostate adenocarcinoma"
       ],
       "instruments": [
         "Q Exactive"
@@ -2573,8 +2573,8 @@
         "Homo sapiens"
       ],
       "diseases": [
-        "uninfected",
-        "obesity"
+        "obesity",
+        "uninfected"
       ],
       "instruments": [
         "Q Exactive HF"
@@ -2651,11 +2651,11 @@
         "Homo sapiens"
       ],
       "diseases": [
-        "neuroblastoma",
+        "lung adenocarcinoma",
+        "breast cancer",
         "colon cancer",
         "epithelial cervix carcinoma",
-        "breast cancer",
-        "lung adenocarcinoma"
+        "neuroblastoma"
       ],
       "instruments": [
         "Q Exactive"
@@ -2925,8 +2925,8 @@
         "Homo sapiens"
       ],
       "diseases": [
-        "control",
-        "squamous  cell carcinoma"
+        "squamous  cell carcinoma",
+        "control"
       ],
       "instruments": [
         "Q Exactive Plus"
@@ -2978,8 +2978,8 @@
         "Homo sapiens"
       ],
       "diseases": [
-        "control",
-        "squamous cell carcinoma"
+        "squamous cell carcinoma",
+        "control"
       ],
       "instruments": [
         "Q Exactive Plus"
@@ -3205,8 +3205,8 @@
         "Homo sapiens"
       ],
       "diseases": [
-        "Normal Colorectum",
-        "Colorectal cancer"
+        "Colorectal cancer",
+        "Normal Colorectum"
       ],
       "instruments": [
         "LTQ Orbitrap Velos"
@@ -3612,8 +3612,8 @@
         "Homo sapiens"
       ],
       "diseases": [
-        "malignant melanoma",
-        "amelanotic melanoma"
+        "amelanotic melanoma",
+        "malignant melanoma"
       ],
       "instruments": [
         " Orbitrap Elite"
@@ -3714,15 +3714,15 @@
         "homo sapiens"
       ],
       "diseases": [
-        "non-small cell lung adenocarcinoma",
-        "amelanotic melanoma",
-        "astrocytoma",
+        "colon adenocarcinoma",
         "renal cell carcinoma",
-        "ovarian serous cystadenocarcinoma",
+        "astrocytoma",
+        "invasive ductal carcinoma",
         "childhood T acute lymphoblastic leukemia",
-        "colon adenocarcinoma",
-        "prostate carcinoma",
-        "invasive ductal carcinoma"
+        "ovarian serous cystadenocarcinoma",
+        "amelanotic melanoma",
+        "non-small cell lung adenocarcinoma",
+        "prostate carcinoma"
       ],
       "instruments": [
         "Orbitrap Elite"
@@ -3748,34 +3748,34 @@
         "homo sapiens"
       ],
       "diseases": [
-        "non-small cell lung adenocarcinoma",
         "clear cell renal carcinoma",
-        "adult T acute lymphoblastic leukemia",
-        "amelanotic melanoma",
-        "high grade ovarian serous adenocarcinoma",
-        "melanoma",
-        "metastatic melanoma",
-        "Ovarian Endometrioid Adenocarcinoma",
-        "adult acute myeloid leukemia",
-        "brain glioblastoma",
-        "astrocytoma",
-        "Colon adenocarcinoma",
-        "renal cell carcinoma",
+        "colon carcinoma",
+        "childhood T acute lymphoblastic leukemia",
         "ovarian serous cystadenocarcinoma",
-        "lung adenocarcinoma",
-        "breast adenocarcinoma",
         "Pleural Epithelioid Mesothelioma",
-        "non-small cell lung carcinoma",
-        "anaplastic large cell lymphoma",
         "chronic myelogenous leukemia",
+        "cutaneous melanoma",
+        "lung adenocarcinoma",
+        "anaplastic large cell lymphoma",
+        "astrocytoma",
+        "non-small cell lung carcinoma",
+        "Colon adenocarcinoma",
+        "breast adenocarcinoma",
+        "Ovarian Endometrioid Adenocarcinoma",
+        "high grade ovarian serous adenocarcinoma",
         "multiple myeloma",
-        "childhood T acute lymphoblastic leukemia",
         "invasive ductal carcinoma",
+        "non-small cell lung adenocarcinoma",
         "gliosarcoma",
-        "colon carcinoma",
         "colon adenocarcinoma",
-        "cutaneous melanoma",
-        "prostate carcinoma"
+        "renal cell carcinoma",
+        "brain glioblastoma",
+        "melanoma",
+        "amelanotic melanoma",
+        "metastatic melanoma",
+        "prostate carcinoma",
+        "adult T acute lymphoblastic leukemia",
+        "adult acute myeloid leukemia"
       ],
       "instruments": [
         "LTQ Orbitrap XL ETD"
@@ -3801,34 +3801,34 @@
         "homo sapiens"
       ],
       "diseases": [
-        "non-small cell lung adenocarcinoma",
         "clear cell renal carcinoma",
-        "adult T acute lymphoblastic leukemia",
-        "amelanotic melanoma",
-        "high grade ovarian serous adenocarcinoma",
-        "melanoma",
-        "metastatic melanoma",
-        "Ovarian Endometrioid Adenocarcinoma",
-        "adult acute myeloid leukemia",
-        "brain glioblastoma",
-        "astrocytoma",
-        "renal cell carcinoma",
+        "colon carcinoma",
+        "childhood T acute lymphoblastic leukemia",
         "ovarian serous cystadenocarcinoma",
-        "lung adenocarcinoma",
-        "breast adenocarcinoma",
         "Pleural Epithelioid Mesothelioma",
+        "chronic myelogenous leukemia",
+        "cutaneous melanoma",
+        "lung adenocarcinoma",
         "anaplastic large cell lymphoma",
+        "astrocytoma",
         "non-small cell lung carcinoma",
-        "chronic myelogenous leukemia",
+        "breast adenocarcinoma",
+        "Ovarian Endometrioid Adenocarcinoma",
+        "high grade ovarian serous adenocarcinoma",
         "multiple myeloma",
-        "childhood T acute lymphoblastic leukemia",
-        "rectosigmoid adenocarcinoma",
         "invasive ductal carcinoma",
+        "non-small cell lung adenocarcinoma",
         "gliosarcoma",
-        "colon carcinoma",
         "colon adenocarcinoma",
-        "cutaneous melanoma",
-        "prostate carcinoma"
+        "renal cell carcinoma",
+        "brain glioblastoma",
+        "melanoma",
+        "amelanotic melanoma",
+        "metastatic melanoma",
+        "prostate carcinoma",
+        "adult T acute lymphoblastic leukemia",
+        "rectosigmoid adenocarcinoma",
+        "adult acute myeloid leukemia"
       ],
       "instruments": [
         "LTQ Orbitrap XL ETD"
@@ -3953,8 +3953,8 @@
       "num_samples": 28,
       "num_columns": 32,
       "organisms": [
-        "homo sapiens",
-        "mus musculus"
+        "mus musculus",
+        "homo sapiens"
       ],
       "diseases": [],
       "instruments": [
@@ -4164,8 +4164,8 @@
       ],
       "diseases": [
         "recessive dystrophyic epidermolysis bullosa cutaneous squamous cell carcinoma",
-        "Low-risk cutaneous squamous cell carcinoma",
-        "metastasizing cutaneous squamous cell carcinoma"
+        "metastasizing cutaneous squamous cell carcinoma",
+        "Low-risk cutaneous squamous cell carcinoma"
       ],
       "instruments": [
         "Q Exactive Plus"
@@ -4217,42 +4217,42 @@
         "homo sapiens"
       ],
       "diseases": [
-        "Alzheimer's disease/Parkinson's disease5",
+        "Parkinson's disease7",
         "control6",
-        "Alzheimer's disease 8",
-        "Parkinson's disease5",
+        "Alzheimer's disease/Parkinson's disease0",
         "Alzheimer's disease 3",
-        "Parkinson's disease6",
-        "control7",
-        "Alzheimer's disease/Parkinson's disease9",
-        "Alzheimer's disease/Parkinson's disease7",
+        "Parkinson's disease4",
         "Alzheimer's disease 7",
-        "Alzheimer's disease 6",
-        "Parkinson's disease7",
-        "control8",
-        "Parkinson's disease3",
-        "Alzheimer's disease0",
-        "Alzheimer's disease/Parkinson's disease3",
-        "control0",
-        "Parkinson's disease9",
+        "Alzheimer's disease",
+        "Alzheimer's disease 8",
         "Parkinson's disease0",
-        "Alzheimer's disease/Parkinson's disease",
         "Alzheimer's disease 9",
+        "Parkinson's disease5",
+        "control4",
         "control",
-        "Alzheimer's disease/Parkinson's disease0",
-        "Alzheimer's disease",
-        "Parkinson's disease",
-        "control3",
-        "Alzheimer's disease/Parkinson's disease4",
-        "Alzheimer's disease/Parkinson's disease8",
         "Parkinson's disease8",
-        "control4",
-        "Alzheimer's disease/Parkinson's disease6",
-        "Alzheimer's disease 5",
-        "control5",
         "Alzheimer's disease 4",
+        "Parkinson's disease6",
         "control9",
-        "Parkinson's disease4"
+        "Alzheimer's disease/Parkinson's disease7",
+        "Alzheimer's disease/Parkinson's disease8",
+        "control0",
+        "control5",
+        "Alzheimer's disease0",
+        "Alzheimer's disease/Parkinson's disease6",
+        "Parkinson's disease",
+        "Alzheimer's disease/Parkinson's disease4",
+        "Parkinson's disease3",
+        "control7",
+        "Alzheimer's disease/Parkinson's disease3",
+        "Alzheimer's disease/Parkinson's disease",
+        "Alzheimer's disease 5",
+        "Alzheimer's disease/Parkinson's disease9",
+        "Alzheimer's disease 6",
+        "Alzheimer's disease/Parkinson's disease5",
+        "control8",
+        "Parkinson's disease9",
+        "control3"
       ],
       "instruments": [
         "Orbitrap Fusion"
@@ -4380,13 +4380,13 @@
         "Homo sapiens"
       ],
       "diseases": [
+        "medulallary carcinoma",
         "primary breast tumor",
+        "primary ductal carcinoma",
+        "metastatic carcinoma",
         "breast carcinoma",
         "ductal carcinoma",
         "fibrocystic disease",
-        "medulallary carcinoma",
-        "metastatic carcinoma",
-        "primary ductal carcinoma",
         "primary acantholytic squamous cell carcinoma"
       ],
       "instruments": [
@@ -4539,12 +4539,12 @@
         "Homo Sapiens"
       ],
       "diseases": [
-        "basal-like breast carcinoma",
         "Normal Breast-Like Subtype of Breast Carcinoma",
         "breast cancer",
         "luminal A breast carcinoma",
+        "luminal B breast carcinoma",
         "HER2 Positive Breast Carcinoma",
-        "luminal B breast carcinoma"
+        "basal-like breast carcinoma"
       ],
       "instruments": [
         "Q Exactive"
@@ -4594,10 +4594,10 @@
         "Homo sapiens"
       ],
       "diseases": [
-        "compensated hypertrophy",
-        "cardiac hypertrophy",
         "ischemic cardiomyopathy",
-        "dilated cardiomyopathy"
+        "compensated hypertrophy",
+        "dilated cardiomyopathy",
+        "cardiac hypertrophy"
       ],
       "instruments": [
         "Q Exactive"
@@ -4772,13 +4772,13 @@
         "Homo sapiens"
       ],
       "diseases": [
+        "other",
+        "mucosal",
+        "acral lentiginous melanoma",
         "unknown",
         "superficial spreading melanoma",
         "lentigo maligna melanoma",
-        "other",
-        "nodular melanoma",
-        "mucosal",
-        "acral lentiginous melanoma"
+        "nodular melanoma"
       ],
       "instruments": [
         "Q Exactive Plus",
@@ -4854,9 +4854,9 @@
       ],
       "diseases": [],
       "instruments": [
+        "Orbitrap Fusion Lumos",
         "Q Exactive HF",
-        "Q Exactive Plus",
-        "Orbitrap Fusion Lumos"
+        "Q Exactive Plus"
       ],
       "acquisition_methods": [
         "Data-dependent acquisition"
@@ -4932,14 +4932,14 @@
         "Homo sapiens"
       ],
       "diseases": [
-        "'Crohn''s Disease Irritable Bowel Syndrome'",
-        "Healthy control",
+        "Ulcerative Colitis active stage",
         "Ulcerative Colitis remission stage",
-        "Irritable Bowel Syndrome",
+        "'Crohn''s Disease Irritable Bowel Syndrome'",
         "Colon Adenoma",
-        "Gastric Carcinoma",
         "'Crohn''s Disease'",
-        "Ulcerative Colitis active stage"
+        "Healthy control",
+        "Irritable Bowel Syndrome",
+        "Gastric Carcinoma"
       ],
       "instruments": [
         "Q Exactive HF"
@@ -5269,8 +5269,8 @@
         "homo sapiens"
       ],
       "diseases": [
-        "non-alcoholic fatty liver disease",
         "cirrhosis of liver",
+        "non-alcoholic fatty liver disease",
         "type II diabetes mellitus"
       ],
       "instruments": [
@@ -5372,8 +5372,8 @@
         "Homo sapiens"
       ],
       "diseases": [
-        "Non-demented control",
         "Alzheimer's diseasemedial",
+        "Non-demented control",
         "Alzheimer's disease"
       ],
       "instruments": [
@@ -5551,8 +5551,8 @@
       ],
       "diseases": [],
       "instruments": [
-        "Q Exactive Plus",
-        "TSQ Quantiva"
+        "TSQ Quantiva",
+        "Q Exactive Plus"
       ],
       "acquisition_methods": [
         "selected reaction monitoring"
@@ -5929,9 +5929,9 @@
       ],
       "diseases": [
         "gastric carcinoma",
+        "Hepatoblastoma",
         "epithelial cervix carcinoma",
-        "Colorectal cancer",
-        "Hepatoblastoma"
+        "Colorectal cancer"
       ],
       "instruments": [
         "Orbitrap Fusion Lumos"
@@ -5983,8 +5983,8 @@
         "Homo sapiens"
       ],
       "diseases": [
-        "breast cancer",
-        "nontumorigenic"
+        "nontumorigenic",
+        "breast cancer"
       ],
       "instruments": [
         "LTQ"
@@ -6212,8 +6212,8 @@
         "Homo sapiens"
       ],
       "diseases": [
-        "non-small cell lung cancer",
-        "small cell lung cancer"
+        "small cell lung cancer",
+        "non-small cell lung cancer"
       ],
       "instruments": [
         " Orbitrap Fusion Lumos"
@@ -6286,9 +6286,9 @@
       "num_samples": 360,
       "num_columns": 32,
       "organisms": [
-        "plasmodium falciparum",
+        "plasmodium knowlesi",
         "Homo sapiens",
-        "plasmodium knowlesi"
+        "plasmodium falciparum"
       ],
       "diseases": [],
       "instruments": [
@@ -6362,8 +6362,8 @@
       "num_samples": 160,
       "num_columns": 31,
       "organisms": [
-        "plasmodium falciparum",
-        "plasmodium knowlesi"
+        "plasmodium knowlesi",
+        "plasmodium falciparum"
       ],
       "diseases": [],
       "instruments": [
@@ -6387,8 +6387,8 @@
       "num_samples": 160,
       "num_columns": 31,
       "organisms": [
-        "plasmodium falciparum",
-        "plasmodium knowlesi"
+        "plasmodium knowlesi",
+        "plasmodium falciparum"
       ],
       "diseases": [],
       "instruments": [
@@ -6412,8 +6412,8 @@
       "num_samples": 160,
       "num_columns": 31,
       "organisms": [
-        "plasmodium falciparum",
-        "plasmodium knowlesi"
+        "plasmodium knowlesi",
+        "plasmodium falciparum"
       ],
       "diseases": [],
       "instruments": [
@@ -6542,8 +6542,8 @@
       ],
       "diseases": [],
       "instruments": [
-        "Q Exactive Plus",
-        "Orbitrap Velos Pro"
+        "Orbitrap Velos Pro",
+        "Q Exactive Plus"
       ],
       "acquisition_methods": [
         "Data-dependent acquisition"
@@ -6613,14 +6613,14 @@
       "num_samples": 720,
       "num_columns": 30,
       "organisms": [
-        "Bifidobacterium longum",
-        "Bacteroides thetaiotaomicron",
+        "Blautia producta",
         "Clostridium butyricum",
-        "lactobacillus",
         "Anaerostipes caccae",
         "Escherichia coli K-12",
-        "Blautia producta",
-        "clostridium"
+        "lactobacillus",
+        "Bifidobacterium longum",
+        "clostridium",
+        "Bacteroides thetaiotaomicron"
       ],
       "diseases": [],
       "instruments": [
@@ -6676,8 +6676,8 @@
         "chronic myelogenous leukemia"
       ],
       "instruments": [
-        "Q Exactive Plus",
-        "Orbitrap Fusion Lumos"
+        "Orbitrap Fusion Lumos",
+        "Q Exactive Plus"
       ],
       "acquisition_methods": [
         "Data-dependent acquisition"
@@ -6753,8 +6753,8 @@
       ],
       "diseases": [],
       "instruments": [
-        "Q Exactive Plus",
-        "Orbitrap Fusion Lumos"
+        "Orbitrap Fusion Lumos",
+        "Q Exactive Plus"
       ],
       "acquisition_methods": [
         "Data-dependent acquisition"
@@ -6777,8 +6777,8 @@
         "Homo sapiens"
       ],
       "diseases": [
-        "adenocarcinoma",
-        "colon cancer"
+        "colon cancer",
+        "adenocarcinoma"
       ],
       "instruments": [
         "Q Exactive HF"
@@ -7088,10 +7088,10 @@
         "Orbitrap Exploris 480"
       ],
       "acquisition_methods": [
-        "Data-dependent acquisition",
-        "Data-independent acquisition"
+        "Data-independent acquisition",
+        "Data-dependent acquisition"
       ],
-      "experiment_type": "DDA",
+      "experiment_type": "DIA",
       "label_type": "Label-free",
       "template": "unknown",
       "version": "unknown"
@@ -7233,16 +7233,16 @@
         "homo sapiens"
       ],
       "diseases": [
+        "native_5",
+        "decellularized_4",
         "decellularized_2",
         "native_3",
-        "decellularized_4",
-        "native_5",
-        "decellularized_3",
-        "decellularized_1",
         "native_2",
         "native_1",
+        "decellularized_3",
         "decellularized_5",
-        "native_4"
+        "native_4",
+        "decellularized_1"
       ],
       "instruments": [
         "LTQ"
@@ -7393,8 +7393,8 @@
       ],
       "diseases": [],
       "instruments": [
-        "SCIEX instrument model",
-        "TripleTOF 5600+"
+        "TripleTOF 5600+",
+        "SCIEX instrument model"
       ],
       "acquisition_methods": [
         "data-dependent acquisition"
@@ -8072,8 +8072,8 @@
       ],
       "diseases": [],
       "instruments": [
-        "Q Exactive HF-X",
-        "timsTOF Pro 2"
+        "timsTOF Pro 2",
+        "Q Exactive HF-X"
       ],
       "acquisition_methods": [
         "data-dependent acquisition"
diff --git a/site/sdrf-explorer.html b/site/sdrf-explorer.html
index 8c08fe4c..95df8914 100644
--- a/site/sdrf-explorer.html
+++ b/site/sdrf-explorer.html
@@ -218,7 +218,6 @@
                 <a href="./sdrf-explorer.html" class="active">Explorer</a>
                 <a href="./sdrf-editor.html">Editor</a>
                 <a href="./index.html#contributors">Contributors</a>
-                <a href="/dev/" class="version-link">Dev Version</a>
                 <a href="https://github.com/bigbio/proteomics-metadata-standard" target="_blank">GitHub</a>
             </nav>
         </div>
diff --git a/site/sdrf-terms.html b/site/sdrf-terms.html
index 206ceded..ce1db14c 100644
--- a/site/sdrf-terms.html
+++ b/site/sdrf-terms.html
@@ -366,7 +366,6 @@
             <a href="./sdrf-explorer.html">Explorer</a>
             <a href="./sdrf-editor.html">Editor</a>
             <a href="./index.html#contributors">Contributors</a>
-            <a href="/dev/" class="version-link">Dev Version</a>
             <a href="https://github.com/bigbio/proteomics-metadata-standard" target="_blank">GitHub</a>
         </nav>
     </header>